Compare GEO & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEO | OCUL |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1996 | 2014 |
| Metric | GEO | OCUL |
|---|---|---|
| Price | $16.80 | $7.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $39.67 | $23.56 |
| AVG Volume (30 Days) | 2.5M | ★ 4.8M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 727.27 | N/A |
| EPS | ★ 1.82 | N/A |
| Revenue | ★ $2,263,420,000.00 | $1,990,000.00 |
| Revenue This Year | $13.74 | $7.93 |
| Revenue Next Year | $9.99 | $94.00 |
| P/E Ratio | $9.51 | ★ N/A |
| Revenue Growth | ★ 3.85 | 3.48 |
| 52 Week Low | $12.51 | $6.23 |
| 52 Week High | $32.09 | $16.44 |
| Indicator | GEO | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 34.58 |
| Support Level | $16.52 | $6.23 |
| Resistance Level | $17.64 | $12.38 |
| Average True Range (ATR) | 0.71 | 0.41 |
| MACD | 0.25 | -0.11 |
| Stochastic Oscillator | 78.05 | 1.20 |
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.